Showing 501 - 520 results of 1,384 for search '"platelet"', query time: 0.06s Refine Results
  1. 501

    Elevated Neutrophil Lymphocyte Ratio in Recurrent Optic Neuritis by Hande Guclu, Sadık Altan Ozal, Vuslat Pelitli Gurlu, Ramazan Birgul

    Published 2015-01-01
    “…To demonstrate the relation between optic neuritis (ON) and systemic inflammation markers as neutrophil lymphocyte ratio (N/L ratio), platelet count, mean platelet volume (MPV), and red cell distribution width (RDW) and furthermore to evaluate the utilization of these markers to predict the frequency of the ON episodes. …”
    Get full text
    Article
  2. 502

    The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current Evidence by Kamran Qureshi, Shyam Patel, Andrew Meillier

    Published 2016-01-01
    “…These agents seem promising in raising platelet counts before elective procedures resulting in reduction in platelet transfusions, and they also enabled more patients to undergo the procedures. …”
    Get full text
    Article
  3. 503

    Thrombocytopenia in Plasmodium vivax Malaria: How Significant? by Arti Muley, Jitendra Lakhani, Saurabh Bhirud, Abhinam Patel

    Published 2014-01-01
    “…A total of 66 patients were included. 42 (63%) had platelet count <100000/mm3. Mean platelet count was 1,18,650, range being 8000/mm3–6,10,000/mm3. …”
    Get full text
    Article
  4. 504

    A Curious Case of Pseudothrombocytopenia due to In Vitro Agglutination by Le Zhong, Juskaran Chadha, Ali Ameri

    Published 2020-01-01
    “…The EDTA-dependent mechanism of PTCP occurs due to a conformational change of platelet surface glycoprotein IIb/IIIa (GPIIb/IIIa) caused by EDTA, which allows natural IgM or IgG auto-antibodies to bind to GPIIb/IIIa, leading to platelet agglutination. …”
    Get full text
    Article
  5. 505

    Impact of antiplatelet therapy on hemostatic plug formation in the setting of thrombocytopenia by Robert H. Lee, Abigail Ballard-Kordeliski, Summer R. Jones, Wolfgang Bergmeier

    Published 2025-01-01
    “…Objectives: To systematically investigate the combined effect of thrombocytopenia and APT in mouse models of hemostasis and thrombosis. Methods: Platelet-depleted mice were repleted with donor platelets inhibited with aspirin and/or clopidogrel at low (<1 × 108/mL) or normal (>2) platelet counts. …”
    Get full text
    Article
  6. 506

    Rivaroxaban Treatment for Heparin-Induced Thrombocytopenia: A Case Report and a Review of the Current Experience by Mohamed Aon, Omar Al-Shammari

    Published 2020-01-01
    “…Direct oral anticoagulants do not cause platelet activation in the presence of heparin-platelet factor 4 antibodies, nor do they provoke autoantibody production. …”
    Get full text
    Article
  7. 507

    Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report by O. P. Arewa, S. Nahirniak, G. Clarke

    Published 2013-01-01
    “…PTP is caused by alloimmunization to human platelet specific antigens following blood component transfusion. …”
    Get full text
    Article
  8. 508

    The Role of PPARs in the Endothelium: Implications for Cancer Therapy by David Bishop-Bailey, Karen E. Swales

    Published 2008-01-01
    “…In addition, inflammation, coagulation, and platelet activation are common signals in the growth and metastasis of tumour cells. …”
    Get full text
    Article
  9. 509

    Performance of PRP Associated with Porous Chitosan as a Composite Scaffold for Regenerative Medicine by Andréa Arruda Martins Shimojo, Amanda Gomes Marcelino Perez, Sofia Elisa Moraga Galdames, Isabela Cambraia de Souza Brissac, Maria Helena Andrade Santana

    Published 2015-01-01
    “…This study aimed to evaluate the in vitro performance of activated platelet-rich plasma associated with porous sponges of chitosan as a composite scaffold for proliferation and osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells. …”
    Get full text
    Article
  10. 510

    Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain by María-Eva Mingot-Castellano, Carlos Grande-García, David Valcárcel-Ferreiras, Clara Conill-Cortés, Loreto de Olivar-Oliver

    Published 2017-01-01
    “…Romiplostim, a thrombopoietin-receptor agonist (TPO-ra), is a highly effective option in primary immune thrombocytopenia (ITP), with 80–90% of patients achieving platelet responses after few weeks of treatment. The evidence showing remissions, that is, sustained platelet counts after romiplostim discontinuation, in patients with ITP refractory to immunosuppressive therapy is steadily increasing. …”
    Get full text
    Article
  11. 511

    Systemic inflammatory indices as a non-invasive grading modality for endometriosis: a comparative study versus exploratory laparoscopy by Ahmed Sabra Ibrahim Mohammed Sabra, Shreen Naguib Aboelezz Moselhy, Ahmed Kasem Mohamed Zain Eldin

    Published 2025-01-01
    “…Abstract Objective: Included evaluation of the possibility of using the systemic inflammatory indices for preoperative screening for the presence and severity of endometriosis (EM) in comparison to the findings of the exploratory laparoscopy Methods: 88 women with clinical manifestations suggestive of EM were evaluated clinically and by US and gave blood samples for estimation of serum cancer antigen-125 (CA125), platelet and total and differential leucocytic counts for calculation of inflammatory indices; the Systemic Immune-Inflammation index, the Systemic Inflammation Response Index (SIRI), the Neutrophil-Lymphocyte ratio (NLR), the Neutrophil-Monocyte ratio, the Neutrophil-Platelet ratio and the Platelet-Lymphocyte ratio. …”
    Get full text
    Article
  12. 512

    A nonactivating ITGB3 mutation in the β3 cytoplasmic region causes macrothrombocytopenia with an impaired αIIbβ3/RhoA pathway by Keiichi Nakata, Keigo Akuta, Takaya Endo, Midori Koike, Daisuke Motooka, Daisuke Okuzaki, Hisashi Kato, Yoshiaki Tomiyama, Naoki Hosen, Hirokazu Kashiwagi

    Published 2025-02-01
    “…Platelet αIIbβ3 and GPVI expression were decreased in KI mice, and αIIbβ3 activation was not detected in nonstimulated KI platelets. …”
    Get full text
    Article
  13. 513

    Recurrent Gastrointestinal Hemorrhage in Children with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with Dasatinib: Case Reports by Xin Liao, Yuxia Guo, Yali Shen, Jianwen Xiao

    Published 2020-01-01
    “…We report three Chinese children with Ph + B-ALL who received a combination treatment of chemotherapy and dasatinib and developed gastrointestinal bleeding several months later. The platelet count and clotting tests were normal, and these patients presented with dasatinib-induced platelet dysfunction. …”
    Get full text
    Article
  14. 514

    An Unusual Cause of Secondary ITP in a 34-Year-Old Hispanic Male by Ayrton Bangolo, Mohamed Ahmed, Ali Atoot, Ashraf Mahmoud, Chibuzo Agbakwuru-Onyike, Maria Karina Larni Y. Palad, Michael Sciarra, Adam Atoot

    Published 2021-01-01
    “…H. pylori eradication has been recommended in the management of ITP with studies showing improvement in the platelet count in some patients. Substantial platelet count increases in patients with severe thrombocytopenia (platelet counts <30 × 103 microliter), however, are uncommon with H. pylori treatment alone. …”
    Get full text
    Article
  15. 515

    Transient Complete Recovery of Chronic Refractory Idiopathic Thrombocytopenic Purpura after Treatment with Monoclonal Antibody Targeting SARS-CoV-2 Spike Protein by Pooja Gogia, Yiqing Xu

    Published 2022-01-01
    “…Idiopathic thrombocytopenic purpura (ITP), also known as immune thrombocytopenic purpura, is an immune-mediated acquired disease characterized by transient or persistent decrease of the platelet count due to autoimmune-related destruction of platelets. …”
    Get full text
    Article
  16. 516

    Successful Management of Acute Catastrophic Juvenile Vaginal Bleeding in Glanzmann’s Thromboasthenia by Uterine Tamponade: A Case Report and Review of The Literature by Nazli Hossain, Tahir S. Shamsi, Adeel Feroz

    Published 2012-01-01
    “…Glanzmann’s thromboasthenia (GT) is a rare platelet disorder, due to membrane defects involving glycoprotein GP IIb/IIIa complex. …”
    Get full text
    Article
  17. 517

    Association of haplotypes for SNPs in the LTR regions of bovine leukemia virus with hematological indices of cattle by N. V. Blazhko, S. Kh. Vyshegurov, A. S. Donchenko, K. S. Shatokhin, T. I. Krytsyna, V. A. Ryabinina

    Published 2019-05-01
    “…We performed the total count of white blood cells (WBC), lymphocyte (lymf), granulocyte (gran), monocyte (mon), red blood cell (RBC), hemoglobin (HGB), hematocrit (HTC), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red blood cell distribution width (RDW), platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), and platelet crit count (PCT). …”
    Get full text
    Article
  18. 518

    Vertebral Artery Thrombosis in Chronic Idiopathic Thrombocytopenic Purpura by Zakaria Hindi, Nirmal Onteddu, Christopher A. Ching, Abdallah A. Khaled

    Published 2017-01-01
    “…Although stroke in patients with ITP is very rare due to thrombocytopenia, it has been reported in several other published cases and is likely associated with increased platelet microparticle levels, a byproduct of platelet destruction. …”
    Get full text
    Article
  19. 519

    Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy by Eric L. Tam, Padma L. Draksharam, Jennifer A. Park, Gurinder S. Sidhu

    Published 2019-01-01
    “…After supportive care, the platelet counts rapidly improved to 76,000/μL. Upon initiation of FOLFIRI and cetuximab chemotherapy, she again developed rectal bleeding and severe thrombocytopenia with a platelet count of 6000/μL. …”
    Get full text
    Article
  20. 520

    Oxford-AstraZeneca Coronavirus Disease-2019 Vaccine-Induced Immune Thrombocytopenia on Day Two by Azhar Kareem Razzaq, Ameer Al-Jasim

    Published 2021-01-01
    “…Immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by platelet damage, life-threatening thrombocytopenia, and haemorrhage when the platelet count reaches below 20 × 109/mcL. …”
    Get full text
    Article